New B2B life science investor Biospring Partners announced the closing of its debut fund with north of $245 million in capital commitments from pension plans, fund of funds, endowments and foundations, and family offices.

According to a press release from the growth equity firm, it aims to invest in companies with the potential to fundamentally shift how technol